Frontier IP Group Plc Parkside Architectural Tiles launch Alusid range and event at the Royal Academy of Engineering

Frontier IP Group Plc (LON:FIPP), a specialist in commercialising university intellectual property, today announces that Parkside Architectural Tiles, the commercial arm of Topps Tiles plc serving the architecture and design market, is to launch an exclusive range of sustainable tiles made by the Group’s portfolio company Alusid (“Alusid” or the “Company”). Frontier IP holds a 35.6 per cent stake in the Company.

Frontier IP chief executive Neil Crabb said: “Alusid continues to thrive and attract new customers and, of course, we’re delighted about the Parkside launch. We believe there is greater demand to be fulfilled, and we are now actively exploring options to transform the company’s manufacturing capacity.”

The tiles will be made from recycled porcelain and glass industrial waste through Alusid’s patented process, which also uses less energy than conventional tile manufacturing.

Parkside will sell the tiles under the brand name Sequel in a range of different formats and colours. They will be launched at this year’s Clerkenwell Design Week in London, from the 21 to 23 May.

Sequel tiles will also be on display at the new Parkside design studio in Clerkenwell.

Alusid, a spin out from the University of Central Lancashire, has already enjoyed success with its SilicaStone-branded tiles, tabletops and other surfaces. Customers include Amazon, Nando’s and Wells Fargo bank, which is using Alusid’s products in its prestigious London HQ. There are more than 100 projects in the pipeline.

The Company raised £1.34 million in September last year to support planning to scale up manufacturing, a move expected to transform capacity from 4,000m2 a year to 30,000m2 a month.

Alusid co-founder and chief operating officer Dr Alasdair Bremner said: We’re very excited about the launch of our new Sequel brand by Parkside Architectural Tiles. Our strategy has always been that customers will not buy a product because it is greener, but because it is of premium quality as well as being sustainable. We believe this launch vindicates that approach.”

Event at the Royal Academy of Engineering

Frontier IP, a specialist in commercialising university intellectual property, is hosting an event jointly with the Royal Academy of Engineering (the “Academy”) on the evening of 8th April 2019.

The event is the first hosted by Frontier IP and the Royal Academy following a collaboration agreement between the two organisations reflecting their shared aims in supporting new engineering and technology companies. The theme of the evening is the circular economy and sustainability.

Guests will include investors and representatives of companies supported by Frontier IP and the Academy, government departments and industry partners. The event will showcase innovative sustainable technologies being supported by Frontier IP and the Royal Academy of Engineering’s Enterprise Hub. No new material information will be disclosed.

Announcements from Pulsiv Solar and Alusid are being released to the London Stock Exchange this morning.

The event is being held at the Royal Academy of Engineering’s headquarters in London. The Frontier IP portfolio companies presenting their technologies are:

· Alusid will be showcasing its sustainable tiles and tabletops made from recycled glass and porcelain industrial waste. It is today announcing that Parkside Architectural Tiles, the commercial arm of Topps Tiles plc serving the architecture and design market, is to launch an exclusive range of sustainable tiles made by the company. More details are in the separate announcement.

· Pulsiv Solar is developing technology to improve the energy efficiency of solar micro-inverters and power converters. The company is today announcing that is has entered into an agreement with Robert Bosch Limited to optimise the design of its solar micro-inverter prototype. More details are in the separate announcement.

· Des Solutio is presenting its greener and safer alternatives to the toxic solvents used for extracting the natural actives found in a host of everyday beauty, personal care, household and pharmaceutical products

· Fieldwork Robotics will be demonstrating a prototype of its raspberry-harvesting robot system, developed in collaboration with Hall Hunter Partnership, one of the UK’s biggest soft fruit growers

· Molendotech will show a SirenBW rapid bathing water testing kit being rolled out commercially by Palintest, a subsidiary of FTSE 100 group Halma plc. The kit cuts the time to detect bacteria in water from more than two days to 20 minutes in the hands of a skilled technician

· Nandi Proteins, which is developing novel ingredients to reduce the amount of fat, sugar and E-number additives in food, will be discussing its technology and the work it is doing with AB Foods, Devro and Coeliac UK

· NTPE will be showing its patented technology to print electronic circuits, sensors and semiconductors onto paper

Frontier IP chief executive officer Neil Crabb said: “We are very much looking forward to showing some of the exciting work being undertaken by our portfolio companies alongside technology supported by the Royal Academy’s Enterprise Hub. Frontier IP and the Royal Academy have shared goals in helping early-stage engineering and technology businesses grow and prosper, and we are delighted to be partnering with them. ”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Frontier IP Group Plc

    More articles like this

    Frontier IP Group Plc

    Animal Lovers and Zoonotic Diseases: 5 Things to Know

    Zoonotic diseases, or zoonoses, are on the rise. That may first bring to mind exotic diseases like Ebola, but the reality is that many zoonotic infections happen closer to home, often during everyday activities. In 2018,

    Frontier IP Group Plc

    AI-based initiatives catalyzing immunotherapy in 2018

    Artificial intelligence (AI) has been dynamically changing the field of drug discovery in several areas, including immunotherapy, oncotherapy, neurological disease, and many more. Described here is an ensemble of the initiatives in place to advance the field of

    Frontier IP Group Plc

    Frontier IP Group Plc appoint N+1 Singer as sole broker

    Frontier IP Group PLC (LON:FIPP), a specialist in commercialising university intellectual property, today announced the appointment of Nplus1 Singer Advisory LLP as the Group’s sole broker with immediate effect. Allenby Capital Limited remains the Group’s Nominated Adviser.

    Frontier IP Group Plc

    Britain’s university spinout sector is thriving

    They are among Britain’s greatest national treasures and a powerful engine of ideas and innovation for the nation’s booming technology industry. But how good are UK universities at commercialising the research and expertise which springs from

    Frontier IP Group Plc

    Exscientia CEO explains how AI is transforming drug discovery

    In recent decades a strange confluence has formed in the pharmaceutical industry. A range of powerful technologies have brought enormous new capabilities to the sector, productivity has been simultaneously declining. Deloitte’s Centre for Health Solutions estimates that projected returns on investment

    Frontier IP Group Plc

    How technology is revolutionising the healthcare industry

    A technology revolution is transforming the healthcare industry, changing everything from how patients are diagnosed and treated to our battle against some of the world’s most serious diseases. It’s a revolution fuelled by new sources of

    Frontier IP Group Plc

    Artificial Intelligence will Revolutionise Drug Discovery

    New technologies are making their way into the healthcare industry and healthcare providers are already experimenting with advances such as smart pill technology, 3D-printed medication, and mobile apps. But probably the biggest potential lies in artificial intelligence

    Frontier IP Group Plc

    Rallybio forges joint venture with U.K. tech firm

    A Farmington biotech startup formed by a trio of former top Alexion executives said it is working on drug discovery with an artificial intelligence company in the United Kingdom. Rallybio, focused on rare diseases, has not yet publicly

    Frontier IP Group Plc

    What is leptospirosis and how can it harm us and our pets?

    Recently reported cases of the often fatal bacterial infection leptospirosis in dogs in Sydney have raised the issue of animal diseases that also affect humans. This zoonotic disease is spread by rats and other rodents. However, this

    Frontier IP Group Plc

    The Robot Uprising Is Here

    The robot uprising is inevitable. Take the world’s first raspberry-picking robot, an autonomous machine that’s in development by Fieldwork Robotics at the University of Plymouth in the UK. This fruit-picking Terminator, so to speak, was developed for

    Frontier IP Group Plc

    The UK’s 50 Most Disruptive Companies Revealed

    After receiving applications from a wide range of early stage and more established companies from across industries, the initial list was whittled down to 100 by D/SRUPTION. The list was then submitted to an expert judging

    Frontier IP Group Plc

    Artificial intelligence in the world of drug discovery

    Charlotte Walker-Osborn, a Partner and Head of Technology Sector (International) at global law-firm Eversheds Sutherland and a legal expert in technology law, explains some of the challenges and potential future of artificial intelligence (AI) in the

    Frontier IP Group Plc

    11 diseases which can cause infection

    Illnesses that can pass from animals to humans are known as zoonotic. They’re surprisingly common: More than six out of every 10 known infectious diseases in people are actually contracted from animals, according to the CDC.